Balan, D.; Vartolomei, M.D.; Magdás, A.; Balan-Bernstein, N.; Voidăzan, S.T.; Mártha, O.
Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer. J. Clin. Med. 2021, 10, 5270.
https://doi.org/10.3390/jcm10225270
AMA Style
Balan D, Vartolomei MD, Magdás A, Balan-Bernstein N, Voidăzan ST, Mártha O.
Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer. Journal of Clinical Medicine. 2021; 10(22):5270.
https://doi.org/10.3390/jcm10225270
Chicago/Turabian Style
Balan, Daniel, Mihai Dorin Vartolomei, Annamária Magdás, Noemi Balan-Bernstein, Septimiu Toader Voidăzan, and Orsolya Mártha.
2021. "Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer" Journal of Clinical Medicine 10, no. 22: 5270.
https://doi.org/10.3390/jcm10225270
APA Style
Balan, D., Vartolomei, M. D., Magdás, A., Balan-Bernstein, N., Voidăzan, S. T., & Mártha, O.
(2021). Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer. Journal of Clinical Medicine, 10(22), 5270.
https://doi.org/10.3390/jcm10225270